Published in Microbiologica on October 01, 1985
Averting a malaria disaster. Lancet (1999) 9.40
Artesunate combinations for treatment of malaria: meta-analysis. Lancet (2004) 7.54
Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet (2002) 4.47
Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet (2008) 4.35
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Rhodococcus equi infection in HIV-infected patients. AIDS (1996) 2.32
Drugs for neglected diseases: a failure of the market and a public health failure? Trop Med Int Health (2001) 2.30
Transmission of HIV-associated tuberculosis to health-care workers. Lancet (1992) 2.23
Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal. Trop Med Int Health (2005) 2.18
Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. BMJ (1998) 2.15
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Transmission of HIV-associated tuberculosis to healthcare workers. Infect Control Hosp Epidemiol (1993) 2.02
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 1.90
Leishmaniasis chemotherapy--challenges and opportunities. Clin Microbiol Infect (2011) 1.87
Microscopic diagnosis of sodium acetate-acetic acid-formalin-fixed stool samples for helminths and intestinal protozoa: a comparison among European reference laboratories. Clin Microbiol Infect (2009) 1.85
A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis (2001) 1.84
Immunodiffusion and agglutination tests for Candida in patients with neoplastic disease: inconsistent correlation of results with invasive infections. J Infect Dis (1977) 1.82
Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. Am J Gastroenterol (1999) 1.81
Pharmacokinetics of artemisinin-type compounds. Clin Pharmacokinet (2000) 1.78
Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group. Tuber Lung Dis (1994) 1.72
Immune responses associated with early survival after peroral infection with Toxoplasma gondii. J Immunol (1989) 1.63
Antigen detection in the diagnosis of invasive aspergillosis. Utility in controlled, blinded trials. Ann Intern Med (1983) 1.59
The role of preschool children and day-care centers in the spread of shigellosis in urban communities. J Pediatr (1974) 1.57
Surgical crown lengthening: a 12-month clinical wound healing study. J Periodontol (2001) 1.55
Neurocysticercosis in an Italian traveler to Latin America. Am J Trop Med Hyg (1999) 1.53
Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol (2000) 1.53
Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Trans R Soc Trop Med Hyg (2000) 1.51
A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.48
Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr (2000) 1.46
Immunogenicity of hepatitis B vaccine in term and preterm infants. Acta Paediatr (1998) 1.45
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA study. AIDS (2001) 1.41
Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst Rev (2000) 1.40
A simple scoring system to assess risk of hematological side effects in zidovudine recipients. AIDS (1991) 1.38
The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother (1995) 1.37
SQUID-based microwave cavity search for dark-matter axions. Phys Rev Lett (2010) 1.36
Detection of clonal T cell populations with closely related T cell receptor junctional sequences in persons at high risk for human immunodeficiency virus (HIV) infection and in patients acutely infected with HIV. J Infect Dis (1997) 1.35
Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop (Mars) (1998) 1.35
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. Ann Trop Med Parasitol (1994) 1.34
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts. Infection (2009) 1.33
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Artemisinin and derivatives in the treatment of uncomplicated malaria. Med Trop (Mars) (1998) 1.31
Imported human African trypanosomiasis in Europe, 2005-2009. Euro Surveill (2009) 1.28
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother (2008) 1.26
Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med (1995) 1.26
Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg (1995) 1.26
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. Trans R Soc Trop Med Hyg (2000) 1.24
Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp Parasitol (2000) 1.24
Travel-related imported infections in Europe, EuroTravNet 2009. Clin Microbiol Infect (2011) 1.23
Epidemiological features and case management practices of imported malaria in northern Italy 1991-1995. Trop Med Int Health (1999) 1.22
Identification of two subtypes of serotype 4 human rotavirus by using VP7-specific neutralizing monoclonal antibodies. J Clin Microbiol (1988) 1.20
Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors. Atherosclerosis (2002) 1.19
Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol Res Pract (1996) 1.19
Plasmodium falciparum in vitro susceptibility to antimalarial drugs in Casamance (southwestern Senegal) during the first 5 years of routine use of artesunate-amodiaquine. Antimicrob Agents Chemother (2006) 1.18
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J Infect Dis (2000) 1.18
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010. Euro Surveill (2012) 1.17
Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg (1993) 1.17
Malaria in migrants. Parassitologia (1999) 1.17
Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans R Soc Trop Med Hyg (1996) 1.17
Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. Clin Exp Immunol (1987) 1.16
Prevalence and distribution of soil-transmitted helminth (STH) infections in urban and indigenous schoolchildren in Ortigueira, State of Paranà, Brasil: implications for control. Trop Med Int Health (2000) 1.15
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. Trans R Soc Trop Med Hyg (2000) 1.15
Sexually transmitted diseases in travelers. Clin Infect Dis (2001) 1.15
Artemisinin derivatives for treating severe malaria. Cochrane Database Syst Rev (2000) 1.14
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment. J Infect Dis (2000) 1.14
Dosing accuracy of artesunate and amodiaquine as treatment for falciparum malaria in Casamance, Senegal. Trop Med Int Health (2008) 1.13
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients. Br J Clin Pharmacol (1999) 1.12
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV. Clin Pharmacokinet (2001) 1.11
The placenta and malaria. Ann Trop Med Parasitol (1997) 1.10
Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Italian Collaborative Study Group. Antimicrob Agents Chemother (1998) 1.09
Cerebrospinal fluid linezolid concentrations in postneurosurgical central nervous system infections. Antimicrob Agents Chemother (2002) 1.08
Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran. Bull World Health Organ (2003) 1.06
Experimentally induced peri-implant mucositis. A clinical study in humans. Clin Oral Implants Res (1994) 1.04
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors. J Med Virol (2006) 1.04
Consensus recommendation on the treatment of malaria in Southeast Asia. Southeast Asian J Trop Med Public Health (1998) 1.03
A randomized safety and tolerability trial of artesunate plus sulfadoxine--pyrimethamine versus sulfadoxine-pyrimethamine alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg (2000) 1.03
A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J Antimicrob Chemother (1998) 1.02
Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg (1993) 1.02
Changing species distribution and antimicrobial susceptibility pattern of Shigella over a 29-year period (1980-2008). Epidemiol Infect (2010) 1.02
Chronic HCV infection: epidemiological and clinical relevance. BMC Infect Dis (2012) 1.02
Epidemiological and clinical characteristics and behaviours of individuals with newly diagnosed HIV infection: a multicentre study in north Italy. J Prev Med Hyg (2012) 1.01
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis (2001) 1.01
CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells. J Immunol (2001) 1.01
A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran. Am J Trop Med Hyg (1995) 1.01
The heme moiety of malaria pigment (beta-hematin) mediates the inhibition of nitric oxide and tumor necrosis factor-alpha production by lipopolysaccharide-stimulated macrophages. Exp Parasitol (1995) 1.00
Erysipelothrix rhusiopathiae endocarditis. Eur J Clin Microbiol Infect Dis (1990) 1.00
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. Infection (2008) 0.99
Study on the mechanisms of the antibacterial action of some plant alpha,beta-unsaturated aldehydes. Lett Appl Microbiol (2002) 0.98
Macrophage preconditioning with synthetic malaria pigment reduces cytokine production via heme iron-dependent oxidative stress. Lab Invest (2000) 0.98
The ParaSight-F rapid dipstick antigen capture assay for monitoring parasite clearance after drug treatment of Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1997) 0.98
Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. J Med Virol (2007) 0.98
Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. Int J Pharm (1999) 0.98
Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis B. Lancet (1987) 0.97
Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. J Viral Hepat (2012) 0.97
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. Curr Cancer Drug Targets (2010) 0.97
Outcome and predictive factors of mortality in hospitalized HIV-patients in Burkina Faso. Infection (2009) 0.97